Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1304 (LINC01304) is classified as a long non-coding RNA (lncRNA), specifically a long intergenic non-coding RNA (lincRNA), meaning it is a transcript longer than 200 nucleotides situated between protein-coding genes and does not encode a protein[1][3][5]. These RNAs are generally implicated in the regulation of gene expression at transcriptional and epigenetic levels, often serving as scaffolds for chromatin modifiers, regulators of transcription factor access, or modulators of chromatin architecture[3][5]. There is no evidence that LINC01304 is recognized as a direct therapeutic target (such as a receptor, enzyme, transporter, etc.), nor are any interacting drugs, biomarker status, or specific disease roles currently established in the literature or gene databases available[1]. As with many lincRNAs, research on LINC01304 is limited, and its biological functions remain to be fully elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1304 (LINC01304).